Additional Locations, New Jersey Clinical Trials

A listing of Additional Locations, New Jersey clinical trials actively recruiting patient volunteers.

Filter By
Clear all Advanced
I am/have/had
added new label for I am/have/had
more
I am looking for
added new label for I am looking for
more
Advanced Filters
Found 95 clinical trials
Tipifarnib for the Treatment of Advanced Solid Tumors Lymphoma or Histiocytic Disorders With HRAS Gene Alterations a Pediatric MATCH Treatment Trial

This phase II pediatric MATCH trial studies how well tipifarnib works in treating patients with solid tumors that have spread to other places in the body (advanced), lymphoma, or histiocytic disorders that have HRAS genetic alterations. Tipifarnib may block the growth of cancer cells that have specific genetic changes in …

hodgkin's disease
cns tumor
HRAS
pleural effusion
anti-cancer agents
Children's Hospital of Philadelphia
 (9.4 away) Contact site
  • 0 views
  • 19 Feb, 2024
  • +82 other locations
API Trial-T2

API Trial-T12

Test AP Sit1
 (9.4 away) Contact site
  • 0 views
  • 18 Sep, 2024
  • 1 location
Buprenorphine for Cancer Pain

This study will evaluate patients on both buprenorphine and full agonist opioids (FAO) to assess for withdrawal symptoms. Patients will be evaluated by clinicians and using validated tools to assess for pain and withdrawal. At the same time, patients will use a CPM Rx application on their phone to track …

Fox Chase Cancer Center
 (9.0 away) Contact site
  • 0 views
  • 13 Jan, 2025
  • 1 location
PCSK9i in AAA1236

Please see section 3 of the full protocol Please see section 3 of the full protocol Please see section 3 of the full protocol

Hospital Test1a
 (9.4 away) Contact site
  • 0 views
  • 04 Mar, 2025
  • +1 other locations
PCSK9i in AAA1237

Please see section 3 of the full protocol Please see section 3 of the full protocol Please see section 3 of the full protocol

Hospital Test1a
 (9.4 away) Contact site
  • 0 views
  • 07 May, 2025
  • +1 other locations
PCSK9i in AAA1240

Please see section 3 of the full protocol Please see section 3 of the full protocol Please see section 3 of the full protocol

Hospital Test1a
 (9.4 away) Contact site
  • 0 views
  • 09 May, 2025
  • +1 other locations
PCSK9i in AAA1241

Please see section 3 of the full protocol Please see section 3 of the full protocol Please see section 3 of the full protocol

Hospital Test1a
 (9.4 away) Contact site
  • 0 views
  • 13 May, 2025
  • +1 other locations
IBI3014 in Participants With Unresectable Locally Advanced or Metastatic Solid Tumors

This is a phase 1/2 multicenter, multi-regional, open-label, first-in-human study of IBI3014 in participants with unresectable locally advanced or metastatic solid tumors.

Hospital Test1a
 (9.4 away) Contact site
  • 0 views
  • 22 Aug, 2025
  • +1 other locations
Pulse-low-dose Rate (PLDR) Radiation in Pancreatic Cancer

Standard chemoradiation, followed by surgery are standard treatment plan for patients suffering from pancreatic adenocarcinoma. Due to damage to the surrounding healthy tissue caused by standard radiation, this study uses a new type of radiation plan- pulsed low-dose rate (PLDR) radiation , in combination with chemotherapeutic drug, gemcitabine, given weekly …

chemoradiotherapy
metastatic pancreatic cancer
gemcitabine
adenocarcinoma
kidney function tests
Fox Chase Cancer Center
 (9.0 away) Contact site
  • 0 views
  • 24 Nov, 2025
  • 1 location
Double-Blind Multicenter Study to Evaluate the Efficacy of PLX PAD for the Treatment of COVID-19

This clinical trial will examine if a new treatment of Mesenchymal Stems Cells (called PLX-PAD) can help patients intubated and mechanically ventilated due to COVID-19 to recover more quickly with less complications.

SARS
respiratory distress
acute respiratory distress
covid-19
acute respiratory syndrome (sars)
Thomas Jefferson University
 (7.4 away) Contact site
  • 0 views
  • 19 Feb, 2024
  • +2 other locations